Tumor-specific interendothelial adhesion mediated by FLRT2 facilitates cancer aggressiveness

Blood vessel abnormalization alters cancer cell metabolism and promotes cancer dissemination and metastasis. However, the biological features of the abnormalized blood vessels that facilitate cancer progression and whether they can be targeted therapeutically have not been fully investigated. Here,...

Full description

Bibliographic Details
Main Authors: Ando, T, Tai-Nagara, I, Sugiura, Y, Kusumoto, D, Okabayashi, K, Kido, Y, Sato, K, Saya, H, Navankasattusas, S, Li, DY, Suematsu, M, Kitagawa, Y, Seiradake, E, Yamagishi, S, Kubota, Y
Format: Journal article
Language:English
Published: American Society for Clinical Investigation 2022
_version_ 1797107926572204032
author Ando, T
Tai-Nagara, I
Sugiura, Y
Kusumoto, D
Okabayashi, K
Kido, Y
Sato, K
Saya, H
Navankasattusas, S
Li, DY
Suematsu, M
Kitagawa, Y
Seiradake, E
Yamagishi, S
Kubota, Y
author_facet Ando, T
Tai-Nagara, I
Sugiura, Y
Kusumoto, D
Okabayashi, K
Kido, Y
Sato, K
Saya, H
Navankasattusas, S
Li, DY
Suematsu, M
Kitagawa, Y
Seiradake, E
Yamagishi, S
Kubota, Y
author_sort Ando, T
collection OXFORD
description Blood vessel abnormalization alters cancer cell metabolism and promotes cancer dissemination and metastasis. However, the biological features of the abnormalized blood vessels that facilitate cancer progression and whether they can be targeted therapeutically have not been fully investigated. Here, we found that an axon guidance molecule, fibronectin leucine-rich transmembrane protein 2 (FLRT2), is expressed preferentially in abnormalized vessels of advanced colorectal cancers in humans and that its expression correlates negatively with long-term survival. Endothelial cell-specific deletion of Flrt2 in mice selectively pruned abnormalized vessels, resulting in a unique metabolic state termed "oxygen-glucose uncoupling," which suppressed tumor metastasis. Moreover, Flrt2 deletion caused an increase in the number of mature vessels, resulting in a significant increase in the antitumor effects of immune checkpoint blockers. Mechanistically, we found that FLRT2 forms noncanonical interendothelial adhesions that safeguard against oxidative stress through homophilic binding. Together, our results demonstrated the existence of tumor-specific interendothelial adhesions that enable abnormalized vessels to facilitate cancer aggressiveness. Targeting this type of adhesion complex could be a safe and effective therapeutic option to suppress cancer progression.
first_indexed 2024-03-07T07:21:02Z
format Journal article
id oxford-uuid:32c1a03d-abfe-4a93-8314-616ef64abbfc
institution University of Oxford
language English
last_indexed 2024-03-07T07:21:02Z
publishDate 2022
publisher American Society for Clinical Investigation
record_format dspace
spelling oxford-uuid:32c1a03d-abfe-4a93-8314-616ef64abbfc2022-10-19T06:13:38ZTumor-specific interendothelial adhesion mediated by FLRT2 facilitates cancer aggressivenessJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:32c1a03d-abfe-4a93-8314-616ef64abbfcEnglishSymplectic ElementsAmerican Society for Clinical Investigation2022Ando, TTai-Nagara, ISugiura, YKusumoto, DOkabayashi, KKido, YSato, KSaya, HNavankasattusas, SLi, DYSuematsu, MKitagawa, YSeiradake, EYamagishi, SKubota, YBlood vessel abnormalization alters cancer cell metabolism and promotes cancer dissemination and metastasis. However, the biological features of the abnormalized blood vessels that facilitate cancer progression and whether they can be targeted therapeutically have not been fully investigated. Here, we found that an axon guidance molecule, fibronectin leucine-rich transmembrane protein 2 (FLRT2), is expressed preferentially in abnormalized vessels of advanced colorectal cancers in humans and that its expression correlates negatively with long-term survival. Endothelial cell-specific deletion of Flrt2 in mice selectively pruned abnormalized vessels, resulting in a unique metabolic state termed "oxygen-glucose uncoupling," which suppressed tumor metastasis. Moreover, Flrt2 deletion caused an increase in the number of mature vessels, resulting in a significant increase in the antitumor effects of immune checkpoint blockers. Mechanistically, we found that FLRT2 forms noncanonical interendothelial adhesions that safeguard against oxidative stress through homophilic binding. Together, our results demonstrated the existence of tumor-specific interendothelial adhesions that enable abnormalized vessels to facilitate cancer aggressiveness. Targeting this type of adhesion complex could be a safe and effective therapeutic option to suppress cancer progression.
spellingShingle Ando, T
Tai-Nagara, I
Sugiura, Y
Kusumoto, D
Okabayashi, K
Kido, Y
Sato, K
Saya, H
Navankasattusas, S
Li, DY
Suematsu, M
Kitagawa, Y
Seiradake, E
Yamagishi, S
Kubota, Y
Tumor-specific interendothelial adhesion mediated by FLRT2 facilitates cancer aggressiveness
title Tumor-specific interendothelial adhesion mediated by FLRT2 facilitates cancer aggressiveness
title_full Tumor-specific interendothelial adhesion mediated by FLRT2 facilitates cancer aggressiveness
title_fullStr Tumor-specific interendothelial adhesion mediated by FLRT2 facilitates cancer aggressiveness
title_full_unstemmed Tumor-specific interendothelial adhesion mediated by FLRT2 facilitates cancer aggressiveness
title_short Tumor-specific interendothelial adhesion mediated by FLRT2 facilitates cancer aggressiveness
title_sort tumor specific interendothelial adhesion mediated by flrt2 facilitates cancer aggressiveness
work_keys_str_mv AT andot tumorspecificinterendothelialadhesionmediatedbyflrt2facilitatescanceraggressiveness
AT tainagarai tumorspecificinterendothelialadhesionmediatedbyflrt2facilitatescanceraggressiveness
AT sugiuray tumorspecificinterendothelialadhesionmediatedbyflrt2facilitatescanceraggressiveness
AT kusumotod tumorspecificinterendothelialadhesionmediatedbyflrt2facilitatescanceraggressiveness
AT okabayashik tumorspecificinterendothelialadhesionmediatedbyflrt2facilitatescanceraggressiveness
AT kidoy tumorspecificinterendothelialadhesionmediatedbyflrt2facilitatescanceraggressiveness
AT satok tumorspecificinterendothelialadhesionmediatedbyflrt2facilitatescanceraggressiveness
AT sayah tumorspecificinterendothelialadhesionmediatedbyflrt2facilitatescanceraggressiveness
AT navankasattusass tumorspecificinterendothelialadhesionmediatedbyflrt2facilitatescanceraggressiveness
AT lidy tumorspecificinterendothelialadhesionmediatedbyflrt2facilitatescanceraggressiveness
AT suematsum tumorspecificinterendothelialadhesionmediatedbyflrt2facilitatescanceraggressiveness
AT kitagaway tumorspecificinterendothelialadhesionmediatedbyflrt2facilitatescanceraggressiveness
AT seiradakee tumorspecificinterendothelialadhesionmediatedbyflrt2facilitatescanceraggressiveness
AT yamagishis tumorspecificinterendothelialadhesionmediatedbyflrt2facilitatescanceraggressiveness
AT kubotay tumorspecificinterendothelialadhesionmediatedbyflrt2facilitatescanceraggressiveness